Glenmark Pharma receives USFDA approval for clobetasol propionate
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
Glenmark
Glenmark Pharma receives USFDA approval for Lidocaine Ointment
Glenmark Pharmaceuticals has received final approval from USFDA for its generic version of AstraZeneca’s Xylocaine ointment. The approval is for Lidocaine Ointment USP, 5 per […]
Glenmark recieves USFDA approval for nystatin and triamcinolone acetonide
Glenmark Pharma has received final USFDA approval for anti-fungal ointment nystatin and triamcinolone acetonide.The company also received tentative approval for Olmesartan medoxomil, used for the […]
Glenmark Pharmaceuticals receives USFDA approval for bendamustine hydrochloride
Glenmark Pharmaceuticals has received USFDA final approval for bendamustine hydrochloride for injection, 25 mg/vial and 100 mg/vial, the therapeutic equivalent to the reference listed drug […]
Glenmark Pharma receives USFDA approval for oral contraceptive ethinyl estradiol tablets
Glenmark Pharmaceuticals has received the final USFDA approval for its generic oral contraceptive norgestimate ethinyl estradiol tablets. in strengths of 0.18 mg/0.025 mg, 0.215 mg/ […]
Glenmark Pharma receives USFDA approval for Frovatriptan Succinate
Glenmark Pharma has received USFDA approval to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets, used to treat migraine headaches. The drug Frovatriptan […]
Glenmark Pharma recieves USFDA approval for potassium chloride tablet
Glenmark Pharma has received final USFDA approval to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets […]
Glenmark to initiate novel drug for cancer
Glenmark Pharmaceuticals SA (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals India, has announced the discovery and initiation of investigational new drug enabling studies for […]
Glenmark Pharma recieves USFDA approval for Zyvox
Glenmark Pharmaceuticals has received the USFDA final approval for its anti-bacterial drug Zyvox. The product is the therapeutic equivalent of Zyvox tablets, 600 mg of […]